Robeco Institutional Asset Management’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-939
Closed -$58.8K 1085
2023
Q1
$58.8K Buy
+939
New +$58.6K ﹤0.01% 1006
2022
Q4
Sell
-63,805
Closed -$3.18M 1018
2022
Q3
$3.18M Sell
63,805
-7,581
-11% -$420K 0.01% 584
2022
Q2
$4.2M Sell
71,386
-45,195
-39% -$2.49M 0.01% 540
2022
Q1
$6.17M Buy
116,581
+10,276
+10% +$593K 0.01% 523
2021
Q4
$6.45M Sell
106,305
-48,016
-31% -$2.85M 0.01% 515
2021
Q3
$8.66M Buy
154,321
+150,004
+3,475% +$8.24M 0.02% 481
2021
Q2
$225K Hold
4,317
﹤0.01% 875
2021
Q1
$190K Hold
4,317
﹤0.01% 879
2020
Q4
$151K Hold
4,317
﹤0.01% 874
2020
Q3
$157K Hold
4,317
﹤0.01% 857
2020
Q2
$162K Hold
4,317
﹤0.01% 896
2020
Q1
$158K Hold
4,317
﹤0.01% 902
2019
Q4
$175K Hold
4,317
﹤0.01% 910
2019
Q3
$150K Buy
+4,317
New +$142K ﹤0.01% 922
2014
Q1
Sell
-997
Closed -$36K 749
2013
Q4
$36K Hold
997
﹤0.01% 641
2013
Q3
$30K Hold
997
﹤0.01% 647
2013
Q2
$29K Buy
+997
New +$28.1K ﹤0.01% 631

Other funds holding PBH

Robeco Institutional Asset Management's PBH Position: Q2 2023 in Review

Robeco Institutional Asset Management sold out of Prestige Consumer Healthcare (PBH) in Q2 2023, closing a stake of 939 shares — an estimated $58.8K sold.

Robeco Institutional Asset Management first reported a position in PBH in Q2 2013 and held it in 17 quarters. The position peaked at $8.66M in Q3 2021. 279 funds tracked by Wall St. Rank hold PBH as of Q2 2023.

  • Robeco Institutional Asset Management reported no remaining Prestige Consumer Healthcare position as of Q2 2023 after selling out during the quarter.
  • Robeco Institutional Asset Management sold 939 Prestige Consumer Healthcare shares in Q2 2023, an estimated $58.8K.
  • Robeco Institutional Asset Management first reported a position in Prestige Consumer Healthcare in Q2 2013 and held it in 17 quarters.
  • Robeco Institutional Asset Management's Prestige Consumer Healthcare position peaked at $8.66M in Q3 2021.
  • 279 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2023.

Based on Robeco Institutional Asset Management's 13F filing for Q2 2023, filed 24 Jul 2023.